Cargando…

Redox Balance in Lactobacillus reuteri DSM20016: Roles of Iron-Dependent Alcohol Dehydrogenases in Glucose/ Glycerol Metabolism

Lactobacillus reuteri, a heterofermentative bacterium, metabolizes glycerol via a Pdu (propanediol-utilization) pathway involving dehydration to 3-hydroxypropionaldehyde (3-HPA) followed by reduction to 1,3-propandiol (1,3-PDO) with concomitant generation of an oxidized cofactor, NAD(+) that is util...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lu, Bromberger, Paul David, Nieuwenhuiys, Gavin, Hatti-Kaul, Rajni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193401/ https://www.ncbi.nlm.nih.gov/pubmed/28030590 http://dx.doi.org/10.1371/journal.pone.0168107

Ejemplares similares

Exploring Lactobacillus reuteri DSM20016 as a biocatalyst for transformation of longer chain 1,2-diols: Limits with microcompartment
por: Chen, Lu, et al.
Publicado: (2017)

Autolysis and Cell Death Is Affected by pH in L. reuteri DSM 20016 Cells
por: Zimmerman, Tahl, et al.
Publicado: (2021)

In Silico Genomic and Metabolic Atlas of Limosilactobacillus reuteri DSM 20016: An Insight into Human Health
por: Smythe, Paisleigh, et al.
Publicado: (2022)

Flux analysis of the Lactobacillus reuteri propanediol-utilization pathway for production of 3-hydroxypropionaldehyde, 3-hydroxypropionic acid and 1,3-propanediol from glycerol
por: Dishisha, Tarek, et al.
Publicado: (2014)

The role of Lactobacillus reuteri DSM 17938 for the absorption of iron preparations in children with iron deficiency anemia
por: Manoppo, Jeanette, et al.
Publicado: (2019)

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
por: Saviano, Angela, et al.
Publicado: (2021)

Glycerol conversion to 1, 3-Propanediol is enhanced by the expression of a heterologous alcohol dehydrogenase gene in Lactobacillus reuteri
por: Vaidyanathan, Hema, et al.
Publicado: (2011)

Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants
por: Kaban, Risma K., et al.
Publicado: (2019)

Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938
por: Grande, Rossella, et al.
Publicado: (2017)

Bio-based 3-hydroxypropionic- and acrylic acid production from biodiesel glycerol via integrated microbial and chemical catalysis
por: Dishisha, Tarek, et al.
Publicado: (2015)

Membrane-based continuous fermentation with cell recycling for propionic acid production from glycerol by Acidipropionibacterium acidipropionici
por: Cavero-Olguin, Victor Hugo, et al.
Publicado: (2023)

Assessment of the efficacy of a feed additive consisting of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) DSM 32203 for dogs (NBF LANES)
por: Bampidis, Vasileios, et al.
Publicado: (2022)

The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence
por: Urbańska, Magdalena, et al.
Publicado: (2014)

Human Skin Bacterial Community Response to Probiotic (Lactobacillus reuteri DSM 17938) Introduction
por: Frerejacques, Marie, et al.
Publicado: (2020)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis
por: Gutiérrez-Castrellón, Pedro, et al.
Publicado: (2017)

Impact of the fermentation parameters pH and temperature on stress resilience of Lactobacillus reuteri DSM 17938
por: Hernández, Armando, et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis
por: Gupta, Nitasha, et al.
Publicado: (2020)

Safety and efficacy of Lactobacillus reuteri NBF‐1 (DSM 32203) as a feed additive for dogs
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Safety and efficacy of Lactobacillus reuteri NBF‐2 (DSM 32264) as a feed additive for cats
por: Bampidis, Vasileios, et al.
Publicado: (2019)

The Anti-inflammatory Effects of Glycerol-supplemented Probiotic Lactobacillus reuteri on Infected Epithelial cells In vitro
por: Widyarman, Armelia Sari, et al.
Publicado: (2018)

Lactobacillus reuteri DSM 17938 for managing infant colic: protocol for an individual participant data meta-analysis
por: Sung, Valerie, et al.
Publicado: (2014)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis: Erratum
Publicado: (2018)

Human Breast Milk Promotes the Secretion of Potentially Beneficial Metabolites by Probiotic Lactobacillus reuteri DSM 17938
por: Mai, Tu T., et al.
Publicado: (2019)

Systematic Review with Meta-Analysis: Lactobacillus reuteri DSM 17938 for Treating Acute Gastroenteritis in Children. An Update
por: Patro-Gołąb, Bernadeta, et al.
Publicado: (2019)

Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice
por: West, Christine L., et al.
Publicado: (2020)

Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study
por: Cui, Xuewei, et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial
por: Kołodziej, Maciej, et al.
Publicado: (2017)

Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial
por: Szymański, Henryk, et al.
Publicado: (2017)

Human Breast Milk Promotes the Immunomodulatory Function of Probiotic Lactobacillus reuteri DSM 17938 in the Neonatal Rat Intestine
por: Hoang, Thomas K, et al.
Publicado: (2019)

1,3-Propanediol dehydrogenases in Lactobacillus reuteri: impact on central metabolism and 3-hydroxypropionaldehyde production
por: Stevens, Marc J A, et al.
Publicado: (2011)

Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study
por: Holz, Caterina, et al.
Publicado: (2014)

Lactobacillus reuteri DSM 17938 Probiotics May Increase CC-Chemokine Receptor 7 Expression in Infants Treated With for Colic
por: Savino, Francesco, et al.
Publicado: (2019)

Safety and efficacy of a feed additive consisting of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) DSM 32264 as a feed additive for cats (NBF Lanes s.r.l.)
por: Bampidis, Vasileios, et al.
Publicado: (2022)

Polyphenols and Lactobacillus reuteri in oral health
por: NAUREEN, ZAKIRA, et al.
Publicado: (2022)

Glyceraldehyde-3-Phosphate Dehydrogenase Increases the Adhesion of Lactobacillus reuteri to Host Mucin to Enhance Probiotic Effects
por: Deng, Zhaoxi, et al.
Publicado: (2020)

Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial
por: Mangalat, Nisha, et al.
Publicado: (2012)

The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials
por: Xu, Man, et al.
Publicado: (2015)

Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility
por: Indrio, Flavia, et al.
Publicado: (2017)

Correlation between the Antimicrobial Activity and Metabolic Profiles of Cell Free Supernatants and Membrane Vesicles Produced by Lactobacillus reuteri DSM 17938
por: Maccelli, Alessandro, et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial
por: Kubota, Megumi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_71al2kegh1uovj0nc5emnlngam